Concepedia

Hannah Jörißen

HJ

Statistics

Publications

6

Citations

165

H-Index

6

Active since

2009

Affiliations

Bayer (Germany)(Current)

Fraunhofer Institute for Molecular Biology and Applied Ecology

Bayer (France)

RWTH Aachen University

Hannah Jörißen is an author at Bayer (Germany) specializing in pharmacy, medicinal chemistry, and molecular oncology.

Publications per year

2009–2022

6

Publications

6

Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancer

Hannah Jörißen, Nuran Bektas, Edgar Dahl et al. · BMC Cancer · 2009 · 35 citations · Full text

, , +15

A Novel NAMPT Inhibitor-Based Antibody–Drug Conjugate Payload Class for Cancer Therapy

Niels Böhnke, Markus Berger, Nils Griebenow et al. · Bioconjugate Chemistry · 2022 · 33 citations · Full text

, , +17

Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Hartmut Beck, Tobias Thaler, Daniel Meibom et al. · Journal of Medicinal Chemistry · 2020 · 31 citations · Full text

, , +13

A Human Recombinant Autoantibody-Based Immunotoxin Specific for the Fetal Acetylcholine Receptor Inhibits Rhabdomyosarcoma Growth In Vitro and in a Murine Transplantation Model

Stefan Gattenlöhner, Hannah Jörißen, Michael Hühn et al. · Journal of Biomedicine and Biotechnology · 2010 · 26 citations · Full text

, , +13

Tailored Linker Chemistries for the Efficient and Selective Activation of ADCs with KSPi Payloads

Hans‐Georg Lerchen, Beatrix Stelte‐Ludwig, Anette Sommer et al. · Bioconjugate Chemistry · 2020 · 22 citations

, , +17

1–5 of 6